Lilian Göttig

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 8

Top Venues

Journal of virology

This page only lists publications with an associated author ORCID identifier.

Publications

Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)
Lilian Göttig, Simone Jummer, Luisa Staehler, Peter Groitl, Maryam Karimi, Paola Blanchette, Karin Kosulin, Philip E Branton, Sabrina Schreiner
The human adenovirus PI3K-Akt activator E4orf1 is targeted by the tumor suppressor p53. Journal of virology 98 (4) (2024)

Lilian Göttig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lilian Göttig